← Back to Startups

Fidocure

FidoCure uses genomic testing for canine oncology.

Industry
Bio + Health
Tracked VC backers
1
Visit fidocure.com ↗
View in My Fund →

RiseFinder summary

FidoCure uses genomic testing for canine oncology. Its process uses genomic testing and profiling to identify mutations. The company uses the resulting information to recommend individualized therapeutic options.

Source category

Bio + Health

Category source ↗

Checked

Limited coverage
Tracking coverage and points

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Publicly documented VC backing

These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.

Dated public activity

No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.